Immunophenotypic Features of Acute Myeloid Leukemias Overexpressing the Interleukin 3 Receptor Alpha Chain

References

• Passegué, E., Jamieson, C.H.M., Allies, L.E. and Weissman, I.L. (2003) "Normal and leukemic stem hemopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?", Proc. Natl. Acad. Sci. USA, 100, 11842–11849.
   Google Scholar
• Guan, Y., Gerhard, B. and Hogge, D.E. (2003) "Detection, isolation, and stimulation of quiescent primitive leukemic progeni-tor cells from patients with acute myeloid leukemia (AML)", Blood, 101, 3142–3149.
   Google Scholar
• Hahn, W.C. and Weinberg, R.A. (2002) "Rules for making human tumor cells", N. Engl. J. Med., 347, 1593–1603.
   Google Scholar
• Tenen, D.G. (2003) "Disruption of differentiation in human cancer: AML shows the way", Nature Rev. Cancer, 3, 89–101.
   Google Scholar
• Kelly, L.M., Kutok, J.L., Williams, JR., Boulton, CI., Amaral, S.M., Curley, J., et al. (2002) "PML/RARalpha and FLT3/ITD induce an APL-like disease in mouse model", Proc. Natl. Acad. Sci. USA, 99, 8283–8288.
   Google Scholar
• Dowining, J.R. (2003) "The core-binding factor leukemias: lessons learned from murine models", Curr. Opin. Genet. Development, 13, 48–54.
   Google Scholar
• Yuan, Y., Zhou, L., Miyamoto, T., Iwasaki, H. and Zhang, D.E. (2001) "AMLI-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations", Proc. Natl. Acad. Sci. USA, 98, 10398 — 10403.
   Google Scholar
• Gilliland, D.G. and Griffin, J.D. (2202) "The roles of FLT3 in hematopoiesis and leukemia", Blood, 100, 1532— 1542.
   Google Scholar
• Beghini, A., Peterlongo, P., Rigamonti, C.B., Larizza, L., Cairoli, R., Morra, E., et al. (2000) "c-kit mutations in core binding factor leukemias", Blood, 95, 726–727.
   Google Scholar
• Kyoi, H., Nasc, T., Niakano, Y., Jinnai, I. and Shimazalci, C. (1999) "Prognostic implication of FLT3 and N-RAS mutations in acute myeloid leukemia", Blood, 93, 3074–3080.
   Google Scholar
• Testa, U., Riccioni, R., Militi, S., Coccia, E., Stellacci, E., Samoggia, P., et al. (2002) "Elevated expression of IL-3R a in acute myelogenous leukemia is associated with enhanced blast prolifera-tion, increased cellularity, and poor prognosis", Blood, 100, 2980 — 2988.
   Google Scholar
• Begley, C.J., Woodcock, J.M., Stovoslci, F.C. and Lopez, A.F. (1997) "The structural and functional basis of cytolcine receptor activation: lessons from the common /3 subunit of the granulocyte-macrophage colony stimulating factor, interleukin-3 and IL-5 receptors", Blood, 89, 1471–1482.
   Google Scholar
• Delwel, R., Salem, M., Pellens, C., Dorssers, L., Wagemaker, G., Clarks, S., et al. (1988) "Growth regulation of human acute myeloid leukemia: effects of five recombinant hematopoietic factors in a serum-free culture system", Blood, 72, 1944–1949.
   Google Scholar
• Vellenga, E., Ostapovicz, D., O'Route, B. and Griffin, J.D. (1987) "Effects of recombinant IL-3, GM-CSF, and G.CSF on prolifera-tion of leukemic clonogenic cells in short-term and long-term cultures", Leukemia, 8, 584— 589.
   Google Scholar
• Budel, L.M., Touw, I.P., Delwel, R., Clark, S.C. and Lowenberg, B. (1989) "Interleulcin-3 and granulocyte-macrophage colony-stimu-lating factor receptors on human acute myelocytic leukemia cells and relationship to the proliferative response", Blood, 74, 565 — 571.
   Google Scholar
• Budel, L.M., Elber, 0., Hoogerbrugger, H., Delwel, R., Mahmoud, L.A., Lowenberg, B., et al. (1990) "Common binding structure for granulocyte-macrophage colony stimulating factor and interleulcin-3 on human acute myeloid leukemia cells and monocytes", Blood, 75, 1439 — 1445.
   Google Scholar
• Sun, Q., Woodcock, J.M., Rapoport, A., Stumslci, F.C., Korpelai-nen, El., Ba, CJ., et al. (1996) "Monoclonal antibody 7G3 recognizes the N-terminal domain of the human interleulcin-3 (IL-3) receptor alpha-chain and functions as a specific IL-3 receptor antagonist", Blood, 87, 83–92.
   Google Scholar
• Testa, U., Fossati, C., Samoggia, P., Masciulli, R., Mariani, G., Hassan, H.J., et al. (1996) "Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progeni-tors", Blood, 88, 3391–3406.
   Google Scholar
• Militi, S., Riccioni, R., Parolini, I., Sposi, N.M., Samoggia, P., Pelosi, E., et al. (2001) "Expression of interleulcin 3 and granulocyte-macrophage colony stimulating factor receptor com-mon chain betaC, betaIT in normal hematopoiesis: lineage specificity and proliferation-independent induction", Br. J. Haema-toL, 111, 441–451.
   Google Scholar
• Munoz, L., Nomdedeu, J.F., Lopez, 0., Carnicer, Mi., Bellido, M., Aventin, A., et al. (2001) "Interleulcin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies", Hae-matologica, 86, 1261–1269.
   Google Scholar
• Jordan, CJ., Upchrch, D., Szilvassy, Si., Guzman, ML., Howard, D.S., Pettigrew, AL., et al. (2000) "The interleulcin-3 receptor alpha is a unique marker for human acute myelogenous leukemia stem cells", Leukemia, 14, 1777–1784.
   Google Scholar
• Guzman, ML., Swiderslci, C.F., Howard, D.S., Grimes, BA., Rossi, R.M., Szilvassy, Si., et al. (2002) "Preferential induction of apoptosis for primary human leukemic stem cells", Proc. Natl. Acad. Sci. USA, 99, 16220 — 16225.
   Google Scholar
• Gabbianelli, M., Sargiacomo, M., Pelosi, E., Testa, U., Isacchi, G., et al. (1990) "Pure human hematopoietic progenitors: permissive action of basic fibroblast growth factor", Science, 249, 1561–1564.
   Google Scholar
• Labbaye, C., Valtieri, M. and Testa, U. (1994) "Retinoic acid downmodulates erythroid differentiation and GATA-1 expression in purified adult progenitor culture", Blood, 83, 651–656.
   Google Scholar
• Guerriero, R., Testa, U. and Gabbianelli, M. (1995) "Unilineage megakaryocytic proliferation and differentiation of purified hema-topoietic progeniotrs in serum-free liquid culture", Blood, 86, 3725–3736.
   Google Scholar
• Valet, G., Repp, R., Link, H., Ehninger, A., Gramatzlci, M. and SHG-AML study group. (2003) "Pretherapeutic identification of high-risk acute myeloid leukemia (AML) patients from immuno-phenotypic, cytogenetic, and clinical parameters", Cytometry, 53B, 4 — 10.
   Google Scholar
• Casasnovas, R.O., Slimane, F.K., Garand, R., Faure, G.C., Campos, L., Deneys, V., et al. (2002) "Immunological classification of acute myeloblastic leukemias: relevance to patient outcome", Leukemia, 17, 515–527.
   Google Scholar
• De Waele, M., Renmans, W., Vander Gucht, K., Jachmans, K., Schots, R., Otten, J., et al. (2001) "Growth factor receptor profile of CD34 ± cells in AML and B-lineage ALL and their normal bone marrow counterparts", Eur. J. HaematoL, 66, 178–187.
   Google Scholar
• Kanda, Y., Hamalci, T., Yamamoto, R., Chizuka, A., Suguro, M., Matsuyama, T., et al. (2000) "The clinical significance of CD34 expression in response to therapy of patients with acute myeloid leukemia", Cancer, 88, 2529–2533.
   Google Scholar
• Testa, U., Fossati, C., Samoggia, P., Masciulli, R., Mariani, G., Hassan, Hi., et al. (1996) "Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progeni-tors", Blood, 88, 3391 —3406.
   Google Scholar
• Bene, MC., Bernier, M., Casasnovas, R.O., Gastoldi, G., Knapp, W., Lanza, F., et al. (1998) "The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias", Blood, 92, 596— 599.
   Google Scholar
• Carow, CE., Levenstein, M., Kaufmann, S.H., Chen, J., Amin, S., Rockwell, P., et al. (1996) "Expression of hematopoietic growth factor receptor FLT3 (STK-1/F1k2) in human leukemias", Blood, 87, 1089–1096.
   Google Scholar
• Stirewalt, DL, and Radish, J.P. (2003) "The role of FLT3 in hematopoietic malignancies", Nat. Rev. Cancer, 3, 650–665.
   Google Scholar
• Munoz, L., Villana, N., Jurica, J., Acebedo, G., Domingo, A., Rozman, N., et al. (2003) "Immunophenotypic findings in acute myeloid leukaemia with FLT3 internal tandem duplication", Haematologica, 88, 637–645.
   Google Scholar
• Wetzler, M., McElwain, BK., Stewart, CC., Blumenson, L., Mortazavi, A., Ford, L.A., et al. (2003) "HLA-DR antigen-negative acute myeloid leukaemia", Leukemia, 17, 707–715.
   Google Scholar
• Terstappen, L.W., Safford, M., Konemann, S., Loken, M.R., Zurlutter, K., Buchner, T., et al. (1992) "Flow cytometric characterization of acute myeloid leukemia. PartII. Phenotypic heterogeneity at diagnosis", Leukemia, 6, 70–80.
   Google Scholar
• Amirghofrau, Z., Zakerinia, M. and Shamseddiu, A. (2001) "Significant association between expression of the CD11 b surface molecule and favourable outcome for patients with acute myelo-blastic leukaemia", Int. J. HematoL, 73, 502–506.
   Google Scholar
• Repp, R., Schaekel, U., Helm, G., Thiede, C., Souceck, S., Pascheberg, U., et al. (2003) "Immunophenotyping is an indepen-dent factor for risk stratification in AML", Cytometry, 53B, 11–19.
   Google Scholar
• Armstrong, S.A., Staunton, J.E., Silverman, L.B., Pieters, R., Den Boer, ML., Minden, M.D., et al. (2002) "MLL translocations specify a distinct gene expression profile that distinguishes a unique leukaemia", Nature Genetics, 30, 41 — 47.
   Google Scholar
• Phan, VT., Shultz, D.B., Truoang, B.T.H., Blake, T.J., Brown, AL., Gonda, Ti., et al. (2003) "Cooperation of cytolcine signalling with chimeric transcription factors in leukemogenesis: PML-retinoic acid receptor alpha blocks growth factor-mediated differentiation", MoL Cell. Biol., 23, 4573–4585.
   Google Scholar